Bolt Biotherapeutics, Inc. Common Stock
Symbol: BOLT (NASDAQ)
5.27
0.00 0.000
Company Description:
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Key Stats
- Today's Open: $5.358
- Today's High: $5.37
- Today's Low: $5.265
- Today's Volume: 2.48K
- Yesterday Close: $5.265
- Yesterday High: $5.5
- Yesterday Low: $5.1
- Yesterday Volume: 7.39K
- Last Min Volume: 2
- Last Min High: $5.265
- Last Min Low: $5.265
- Last Min VWAP: $5.265
Company Profile
- Name: Bolt Biotherapeutics, Inc. Common Stock
- Website: https://www.boltbio.com
- Listed Date: 2021-02-05
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001641281
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $10.11M
- Round Lot: 100
- Outstanding Shares: 1.92M
- Asset Type: CS
RECENT FILINGS FOR BOLT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-06 | 8-K | View |
| 2025-06-04 | 8-K | View |
| 2025-05-28 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-05 | 4 | View |
| 2025-05-05 | 4 | View |
| 2025-05-05 | 4 | View |
| 2025-05-05 | 4 | View |
| 2025-04-25 | ARS | View |
| 2025-04-25 | DEF 14A | View |
Latest News on BOLT